Page last updated: 2024-09-05

2-hydroxyhemopyrroline-5-one and Schizophrenia

2-hydroxyhemopyrroline-5-one has been researched along with Schizophrenia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Mulder, RT; Rucklidge, JJ; Sarris, J; Warren, B1
Boers, GH; The, GK; van de Kerkhof, R; van der Meer, JW1
Gorchein, A1

Reviews

1 review(s) available for 2-hydroxyhemopyrroline-5-one and Schizophrenia

ArticleYear
Pyroluria: Fact or Fiction?
    Journal of alternative and complementary medicine (New York, N.Y.), 2021, Volume: 27, Issue:5

    Topics: Adult; Child; Female; Humans; Male; Porphyrias; Pyrroles; Schizophrenia; Vitamin B 6; Vitamin B 6 Deficiency; Zinc

2021

Other Studies

2 other study(ies) available for 2-hydroxyhemopyrroline-5-one and Schizophrenia

ArticleYear
[Hemopyrrollactamuria (HPU); from spots to pseudo-disease].
    Nederlands tijdschrift voor geneeskunde, 2003, Sep-06, Volume: 147, Issue:36

    Topics: Humans; Metabolic Diseases; Porphyrias; Pyrroles; Schizophrenia

2003
Urine concentration of 3-ethyl-5-hydroxy-4,5-dimethyl-delta 3-pyrrolin-2-one ('mauve factor') is not causally related to schizophrenia or to acute intermittent porphyria.
    Clinical science (London, England : 1979), 1980, Volume: 58, Issue:6

    Topics: Acute Disease; Adult; Chromatography, Gas; Female; Humans; Porphyrias; Pyrroles; Schizophrenia

1980